Suppr超能文献

根治性肾切除术治疗 2cm 或更小的肾细胞癌后,全因和心血管死亡率增加。

Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less.

机构信息

Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.

出版信息

J Urol. 2011 Oct;186(4):1247-53. doi: 10.1016/j.juro.2011.05.054. Epub 2011 Aug 17.

Abstract

PURPOSE

We used a large, population based registry to assess whether a difference in overall and cardiovascular survival may exist between radical nephrectomy and partial nephrectomy for renal cell carcinoma 2 cm or less.

MATERIALS AND METHODS

From the SEER (Surveillance, Epidemiology and End Results) registry we identified 4,216 patients with histologically confirmed renal cell carcinoma 2 cm or less who were treated with partial or radical nephrectomy. Patient and tumor characteristics were compared between the 2 patient groups. Multivariate logistic regression was done to predict the odds of undergoing radical nephrectomy. Cardiovascular survival and overall survival were compared between the 2 cohorts, adjusting for patient and tumor characteristics.

RESULTS

Overall 2,301 patients (55%) underwent partial nephrectomy. Partial nephrectomy use steadily increased during the study period from 27% of all cases in 1998 to 66% in 2007. Patients who underwent partial nephrectomy were an average of 2.5 years younger than those treated with radical nephrectomy (56.4 vs 58.9 years, p <0.001). They were more likely to be white and from the western or northeastern United States. Older age was the only independent predictor of radical nephrectomy (OR 1.02, 95% CI 1.01-1.03). When controlling for patient characteristics and surgery year, radical nephrectomy was associated with worse overall mortality (HR 2.24, 95% CI 1.75-2.84) and cardiovascular mortality (HR 2.53, 95% CI 1.51-4.23).

CONCLUSIONS

Radical nephrectomy is associated with worse overall and cardiovascular survival compared to partial nephrectomy in patients with localized renal cell carcinoma 2 cm or less. These findings justify the widespread application of nephron sparing techniques to treat localized kidney cancer.

摘要

目的

我们利用一个大型的基于人群的登记处来评估在 2 厘米或以下的肾细胞癌患者中,根治性肾切除术与部分肾切除术在整体和心血管生存方面是否存在差异。

材料和方法

我们从 SEER(监测、流行病学和最终结果)登记处确定了 4216 名接受部分或根治性肾切除术治疗的组织学证实为 2 厘米或以下的肾细胞癌患者。比较了两组患者的特征。使用多变量逻辑回归预测接受根治性肾切除术的几率。调整患者和肿瘤特征后,比较了两组患者的心血管生存和总体生存情况。

结果

共有 2301 名患者(55%)接受了部分肾切除术。在研究期间,部分肾切除术的使用率稳步上升,从 1998 年所有病例的 27%增加到 2007 年的 66%。接受部分肾切除术的患者比接受根治性肾切除术的患者平均年轻 2.5 岁(56.4 岁比 58.9 岁,p<0.001)。他们更可能是白人,来自美国西部或东北部。年龄较大是接受根治性肾切除术的唯一独立预测因素(OR 1.02,95%CI 1.01-1.03)。当控制患者特征和手术年份时,根治性肾切除术与整体死亡率(HR 2.24,95%CI 1.75-2.84)和心血管死亡率(HR 2.53,95%CI 1.51-4.23)更差相关。

结论

与部分肾切除术相比,根治性肾切除术与 2 厘米或以下局限性肾细胞癌患者的整体和心血管生存更差相关。这些发现证明了广泛应用保肾技术治疗局限性肾癌的合理性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验